Oral Collagen Oligopeptides as a Modulator of Skin Health: A Comprehensive Evaluation of Clinical and Molecular Effects
Journal of Medicinal Food · 2025-09 · 28 (9) · 869-876
DOI: 10.1089/jmf.2024.0252 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Medicinal Food, online erschienen am 26.08.2025. Verfasst von Vivian Zague und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development Department, Genu-in-JBS S/A, São Paulo, Brazil. Hauptthemen laut MEDLINE: Skin, Collagen, Oligopeptides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Collagen peptides (CPs) have been recognized for their potential to enhance skin health, particularly by improving hydration, firmness, and elasticity. However, the molecular mechanisms driving these benefits remain not fully understood, especially regarding their influence on essential extracellular matrix (ECM) components and enzymes that regulate collagen turnover. This study investigated both the clinical efficacy and the underlying preclinical molecular effects of oral collagen oligopeptides (Col-OP) supplementation, aiming to clarify how these peptides contribute to skin improvements. In clinical trials, a double-blind, randomized, placebo-controlled study with 85 women aged 45–60 years examined the effects of daily 2.5 g Col-OP supplementation over 84 days, measuring skin hydration (Corneometer®), firmness, and elasticity (Cutometer®). In addition to clinical studies, preclinical in vitro experiments were conducted on human dermal fibroblast cultures to elucidate the molecular effects of Col-OP. Fibroblasts were treated with noncytotoxic concentrations of Col-OP (10.0, 3.16, and 1.0 mg/mL) for 96 h, assessing the synthesis of type I collagen, matrix metalloproteinase-1 (MMP-1), tissue inhibitor of matrix metalloproteinases (TIMP-1), decorin, versican, biglycan, and hyaluronic acid (HA) through gene expression and enzyme-linked immunosorbent assays. Results showed that Col-OP treatment significantly enhanced gene expression of type I procollagen, decorin, and biglycan while decreasing versican levels ( P < .001). It also promoted type I collagen synthesis and TIMP-1 levels, modulating MMP-1 and HA production. Clinically, Col-OP significantly enhanced skin firmness and elasticity compared with placebo ( P < .05), while improvements in skin hydration did not achieve statistical significance. Based on the current data, it can be concluded that oral supplementation with Col-OP effectively enhances skin health by promoting key ECM components and modulating collagen turnover, offering a promising approach for improving skin health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research and Development Department, Genu-in-JBS S/A, São Paulo, Brazil.
- Department of Clinical Research, Kosmoscience Group, Valinhos, Brazil.
Zitieren
APA
Zague, V., Pinheiro, A. L. T. A., Pinto, J. R., Facchini, G., & Eberlin, S. (2025). Oral Collagen Oligopeptides as a Modulator of Skin Health: A Comprehensive Evaluation of Clinical and Molecular Effects. Journal of Medicinal Food, 28(9), 869-876. https://doi.org/10.1089/jmf.2024.0252
Vancouver
Zague V, Pinheiro ALTA, Pinto JR, Facchini G, Eberlin S. Oral Collagen Oligopeptides as a Modulator of Skin Health: A Comprehensive Evaluation of Clinical and Molecular Effects. Journal of Medicinal Food. 2025;28(9):869-876. doi:10.1089/jmf.2024.0252
BibTeX
@article{Zague2025,
author = {Zague, Vivian and Pinheiro, Ana Lucia Tabarini Alves and Pinto, Juliana Rodrigues and Facchini, Gustavo and Eberlin, Samara},
title = {Oral Collagen Oligopeptides as a Modulator of Skin Health: A Comprehensive Evaluation of Clinical and Molecular Effects},
journal = {Journal of Medicinal Food},
year = {2025},
volume = {28},
number = {9},
pages = {869--876},
doi = {10.1089/jmf.2024.0252}
}
EUVIMED